Ensure Safety, Achieve Compliance, Advance with Confidence

Endotoxins, lipopolysaccharides from Gram-negative bacteria, can induce severe immune reactions and compromise therapeutic safety. Are you facing safety risks, regulatory delays, or product recalls due to endotoxin contamination in your antibody therapeutics? Antibody Endotoxin Level Assessment Service at Creative Biolabs helps you meet strict global quality standards, safeguard patient safety, and maintain batch consistency through highly sensitive detection methods, validated analytical workflows, and expert contamination control strategies. We provide endotoxin testing tailored to antibody therapeutics, enabling faster quality release and lower compliance risk.

What We Can Offer：

• Quantitative endotoxin measurement down to 0.005 EU/mL.
• Compatibility with various antibody formats, including monoclonal, bispecific, and ADCs.
• Validation under GMP-compliant conditions.
• Customized assay selection based on formulation and regulatory pathway.
• Rapid turnaround with optional expedited testing.
• Expert review with actionable recommendations for contamination prevention.

Learn What We Can Do for You – Schedule a Consultation Today.

Strategies

Our approach integrates advanced technologies and tailored methods to maximize accuracy:

• LAL-based detection (gel-clot, chromogenic, turbidimetric) for proven sensitivity.
• Recombinant Factor C assays for animal-free testing with minimal interference.
• Matrix-optimized workflows to reduce false positives or negatives.
• Orthogonal confirmation for critical lots or borderline results.
• Seamless integration with antibody characterization and release testing.
• Root-cause investigation for contamination source tracking.

Workflow

Fig1

Required Materials

• Detailed antibody formulation and concentration data to guide assay optimization.
• Minimum sample volume per assay type, with container type and closure information.
• Any historical endotoxin test data or contamination incidents to refine the testing approach.

Highlights

• Detection sensitivity as low as 0.005 EU/mL for critical-quality applications.
• Assay flexibility to match antibody complexity and formulation properties.
• Rapid, GMP-compliant workflows to accelerate batch release.
• Orthogonal verification to eliminate false positives and negatives.
• Integration with broader antibody QC and release testing programs.

Discover the Creative Biolabs Edge – Request Your Quote Today.

Customer Reviews

• "Ultra-sensitive detection. Using Creative Biolabs' endotoxin testing, we identified low-level contamination before release, preventing a costly product hold." - Dr. K***
• "Matrix-specific optimization. Their tailored approach for our ADC formulation eliminated assay interference and improved result reliability." - Prof. W***
• "Regulatory confidence. The detailed reports met all submission requirements, and we passed agency review without additional data requests." - Dr. S***

FAQs

Extended Services

Creative Biolabs delivers fully integrated quality solutions to ensure your antibody therapeutics meet the highest safety and regulatory standards.

Contact Our Team for More Information and to Discuss Your Project.

Loading case studies...

For research use only. Not intended for any clinical use.